Title: Septra (Trimethoprim and Sulfamethoxazole): Uses, Dosage, Side Effects, Interactions, Warning
Headings: Septra
Septra
Drug Description
What is Septra and how is it used?
What are side effects of Septra?
DESCRIPTION
Indications
INDICATIONS
Urinary Tract Infections
Acute Otitis Media
Acute Exacerbations Of Chronic Bronchitis In Adults
Travelers' Diarrhea In Adults
Shigellosis
Pneumocystis Jirovecii Pneumonia
QUESTION
Dosage
DOSAGE AND ADMINISTRATION
SEPTRA is contraindicated in pediatric patients less than 2 months of age.
Urinary Tract Infections And Shigellosis In Adults And Pediatric Patients And Acute Otitis Media In Pediatric Patients
Pediatric Patients: Two Months of Age or Older
Acute Exacerbations Of Chronic Bronchitis In Adults
Travelers' Diarrhea In Adults
Pneumocystis Jirovecii Pneumonia
HOW SUPPLIED
Side Effects
SIDE EFFECTS
Hematologic
Allergic
Gastrointestinal
Genitourinary
Metabolic
Neurologic
Psychiatric
Endocrine
Musculoskeletal
Respiratory System
Cardiovascular System
Miscellaneous
SLIDESHOW
Drug Interactions
DRUG INTERACTIONS
Potential For SEPTRA To Affect Other Drugs
Drug Interactions With SEPTRA
Drug/Laboratory Test Interactions
Warnings
WARNINGS
Embryofetal Toxicity
Hypersensitivity And Other Serious Or Fatal Reactions
Thrombocytopenia
Streptococcal Infections And Rheumatic Fever
Clostridioides Difficile Associated Diarrhea
Risk Of Failure And Excess Mortality With Leucovorin Use For Pneumocystis jirovecii Pneumonia Treatment
Precautions
PRECAUTIONS
Development Of Drug Resistant Bacteria
Folate Deficiency
Hemolysis
Hypoglycemia
Phenylalanine Metabolism
Porphyria And Hypothyroidism
Use In The Treatment Of And Prophylaxis For Pneumocystis jirovecii Pneumonia In Patients With Acquired Immunodeficiency Syndrome (AIDS)
Electrolyte Abnormalities
Laboratory Tests
Carcinogenesis, Mutagenesis, Impairment Of Fertility
Pregnancy
Teratogenic Effects
Nonteratogenic Effects
See CONTRAINDICATIONS section.
Use in Specific Populations
Nursing Mothers
Pediatric Use
Geriatric Use
REFERENCES
Overdosage & Contraindications
OVERDOSE
Acute
Chronic
CONTRAINDICATIONS
QUESTION
Clinical Pharmacology
CLINICAL PHARMACOLOGY
Pharmacokineticsin Pediatric Patients
Pharmacokinetics In Geriatric Patients
Microbiology
Medication Guide
PATIENT INFORMATION
Health Solutions From Our Sponsors
Septra Drug Imprint
Sulfamethoxazole-Trimethoprim 400 mg-80mg-AMN
Sulfamethoxazole-Trimethoprim DS-AMN
Sulfamethoxazole-Trimethoprim DS-EON
Septra User Reviews

Content: Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis, and Proteus vulgaris. It is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. Acute Otitis Media
For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when, in the judgment of the physician, SEPTRA offers some advantage over the use of other antimicrobial agents. To date, there is limited data on the safety of repeated use of SEPTRA in pediatric patients under two years of age. SEPTRA is not indicated for prophylactic or prolonged administration in otitis media at any age. Acute Exacerbations Of Chronic Bronchitis In Adults
For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when, a physician deems that, SEPTRA could offer some advantage over the use of a single antimicrobial agent. Travelers' Diarrhea In Adults
For the treatment of travelersâ€™ diarrhea due to susceptible strains of enterotoxigenic E. coli. Shigellosis
For the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei when antibacterial therapy is indicated. Pneumocystis Jirovecii Pneumonia
For the treatment of documented Pneumocystis jirovecii pneumonia. For prophylaxis against Pneumocystis jirovecii pneumonia in individuals who are immunosuppressed and considered to be at an increased risk of developing Pneumocystis jirovecii pneumonia.